Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Sarah Billups

Concepts (294)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pharmacists
19
2025
260
4.280
Why?
Hypertension
10
2026
1272
2.410
Why?
Osteoporosis
4
2023
240
2.190
Why?
Primary Health Care
14
2026
1776
1.770
Why?
Remote Consultation
2
2026
67
1.700
Why?
Antihypertensive Agents
6
2026
519
1.630
Why?
Osteoporotic Fractures
3
2023
62
1.550
Why?
Bone Density Conservation Agents
4
2022
83
1.510
Why?
Quality Improvement
4
2026
1354
1.450
Why?
Drug Monitoring
9
2026
399
1.400
Why?
Osteoporosis, Postmenopausal
3
2022
41
1.140
Why?
Medicare Part C
2
2026
39
1.040
Why?
Gout Suppressants
2
2025
18
1.000
Why?
Gout
2
2025
34
0.970
Why?
Pharmaceutical Services
7
2020
76
0.950
Why?
Dermatologists
1
2025
7
0.920
Why?
Acne Vulgaris
1
2025
25
0.910
Why?
Xanthine Oxidase
1
2025
79
0.890
Why?
Blood Pressure
4
2026
1765
0.890
Why?
Drug Costs
2
2025
116
0.880
Why?
Dermatologic Agents
1
2025
69
0.880
Why?
Rheumatic Diseases
1
2026
101
0.840
Why?
Blood Pressure Determination
3
2026
143
0.820
Why?
Rheumatology
1
2026
136
0.820
Why?
Guideline Adherence
4
2025
594
0.780
Why?
Retrospective Studies
26
2026
17438
0.770
Why?
Medicare
2
2026
920
0.770
Why?
Physicians, Primary Care
1
2025
210
0.760
Why?
Maternal Health Services
1
2024
100
0.730
Why?
Pharmacy Service, Hospital
11
2017
90
0.730
Why?
Enzyme Inhibitors
2
2025
823
0.720
Why?
Practice Patterns, Physicians'
5
2025
1408
0.710
Why?
Aged
39
2026
26432
0.700
Why?
Medication Adherence
2
2025
535
0.700
Why?
Urinary Tract Infections
1
2023
209
0.660
Why?
Communicable Diseases
1
2023
166
0.660
Why?
Pre-Exposure Prophylaxis
1
2023
272
0.610
Why?
Patient-Centered Care
1
2024
553
0.570
Why?
Female
50
2026
79499
0.560
Why?
Emergency Service, Hospital
5
2023
2363
0.540
Why?
Cohort Studies
11
2025
6077
0.530
Why?
Aged, 80 and over
12
2026
8391
0.520
Why?
Humans
63
2026
146342
0.520
Why?
Diphosphonates
2
2015
68
0.520
Why?
Education, Pharmacy, Graduate
2
2016
13
0.510
Why?
Health Services Accessibility
1
2026
1107
0.500
Why?
Middle Aged
30
2026
36619
0.500
Why?
Patient Transfer
1
2020
224
0.500
Why?
Blood Pressure Monitoring, Ambulatory
2
2014
69
0.500
Why?
Male
45
2026
73396
0.490
Why?
Pharmacy Residencies
1
2016
10
0.480
Why?
Community Pharmacy Services
2
2013
46
0.470
Why?
Research
2
2016
421
0.460
Why?
Colorado
11
2026
4595
0.460
Why?
Anti-HIV Agents
1
2023
914
0.450
Why?
Telephone
1
2015
175
0.410
Why?
Hospitals, Veterans
9
2001
256
0.400
Why?
Pharmacies
1
2014
40
0.390
Why?
Correspondence as Topic
2
2015
16
0.380
Why?
Patient Satisfaction
5
2013
706
0.380
Why?
Patient Compliance
5
2009
589
0.380
Why?
Adult
19
2026
41087
0.360
Why?
United States
18
2026
16136
0.360
Why?
Health Maintenance Organizations
4
2014
106
0.360
Why?
Professional Role
5
2020
172
0.350
Why?
Prescription Drugs
1
2013
110
0.350
Why?
Delivery of Health Care, Integrated
5
2018
305
0.330
Why?
Insurance, Health
1
2014
318
0.330
Why?
Cost Savings
2
2015
87
0.320
Why?
Neuromuscular Agents
1
2011
46
0.310
Why?
Drug Prescriptions
4
2020
314
0.300
Why?
Drug Therapy
2
2000
85
0.300
Why?
Nortriptyline
1
2009
9
0.290
Why?
Cytochrome P-450 CYP2D6 Inhibitors
1
2009
4
0.290
Why?
Amitriptyline
1
2009
25
0.290
Why?
Antidepressive Agents, Tricyclic
1
2009
30
0.290
Why?
Antidepressive Agents, Second-Generation
1
2009
44
0.280
Why?
Referral and Consultation
2
2026
881
0.270
Why?
Perception
2
2023
373
0.270
Why?
Tetrahydronaphthalenes
2
1998
34
0.270
Why?
HIV Infections
1
2023
3215
0.260
Why?
Calcium Channel Blockers
2
1998
165
0.250
Why?
Health Knowledge, Attitudes, Practice
1
2016
1408
0.250
Why?
Electronic Health Records
4
2026
1210
0.250
Why?
Benzimidazoles
2
1998
191
0.250
Why?
Fractures, Bone
1
2012
436
0.240
Why?
Cholesterol, LDL
2
2025
363
0.240
Why?
Managed Care Programs
2
2013
137
0.230
Why?
Pilot Projects
2
2023
1888
0.230
Why?
Lovastatin
1
2005
37
0.230
Why?
American Heart Association
2
2020
364
0.220
Why?
Simvastatin
1
2005
58
0.220
Why?
Drug-Related Side Effects and Adverse Reactions
4
2018
266
0.210
Why?
Heart Diseases
1
2008
343
0.210
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
3
2025
449
0.210
Why?
Uric Acid
1
2025
167
0.210
Why?
Health Care Costs
2
2014
423
0.200
Why?
Patient Acceptance of Health Care
2
2023
881
0.200
Why?
Bone Density
2
2022
494
0.200
Why?
Academic Medical Centers
2
2024
561
0.200
Why?
Cholesterol
2
2020
411
0.200
Why?
Ambulatory Care
6
2010
628
0.200
Why?
Migraine Disorders
2
2020
109
0.200
Why?
Young Adult
6
2025
14330
0.190
Why?
Gastrointestinal Hemorrhage
1
2024
134
0.190
Why?
Absorptiometry, Photon
1
2023
278
0.180
Why?
Wounds and Injuries
1
2011
959
0.180
Why?
Denosumab
1
2022
10
0.180
Why?
Patient Care Team
3
2024
701
0.180
Why?
Program Evaluation
1
2026
952
0.170
Why?
Practice Guidelines as Topic
3
2020
1591
0.170
Why?
Serotonin 5-HT1 Receptor Agonists
1
2020
3
0.170
Why?
Atherosclerosis
1
2025
410
0.170
Why?
Aspirin
1
2024
405
0.160
Why?
Pregnancy Outcome
1
2024
503
0.160
Why?
Diabetes Mellitus
2
2013
1101
0.160
Why?
Analgesics, Opioid
2
2020
1221
0.150
Why?
Health Promotion
1
2026
786
0.140
Why?
Adolescent
5
2025
22557
0.140
Why?
Quality of Health Care
1
2024
702
0.140
Why?
Glucocorticoids
1
2023
536
0.140
Why?
Student Health Services
1
2018
15
0.140
Why?
Antimanic Agents
1
2018
14
0.140
Why?
Lithium Compounds
1
2018
11
0.140
Why?
Pregnancy Complications
1
2024
609
0.140
Why?
Angina Pectoris
1
1998
76
0.130
Why?
Product Surveillance, Postmarketing
1
1998
74
0.130
Why?
Drug Approval
1
1998
94
0.130
Why?
Cardiovascular Diseases
3
2025
2219
0.130
Why?
Preceptorship
1
2018
68
0.130
Why?
Antidepressive Agents
2
2017
235
0.130
Why?
Attitude of Health Personnel
1
2026
1219
0.130
Why?
Data Collection
4
2014
650
0.130
Why?
Students, Pharmacy
1
2018
96
0.130
Why?
Drug Interactions
4
2012
405
0.120
Why?
Chronic Disease
5
2026
1827
0.120
Why?
Quality of Life
4
2001
3200
0.110
Why?
Antipsychotic Agents
1
2017
185
0.110
Why?
Pharmaceutical Preparations
2
2016
172
0.110
Why?
Monitoring, Physiologic
1
2017
279
0.110
Why?
Administration, Oral
2
2015
872
0.110
Why?
Internship, Nonmedical
1
2015
10
0.110
Why?
Cost-Benefit Analysis
2
2015
640
0.110
Why?
Hematinics
1
2014
22
0.100
Why?
Risk Factors
10
2025
10921
0.100
Why?
Patient Readmission
1
2020
778
0.100
Why?
Renal Insufficiency
2
2015
173
0.100
Why?
United States Department of Veterans Affairs
5
2001
777
0.100
Why?
Follow-Up Studies
3
2013
5439
0.100
Why?
Reminder Systems
1
2015
149
0.100
Why?
Patient Discharge
1
2020
997
0.100
Why?
Educational Measurement
1
2016
331
0.090
Why?
Colchicine
1
2012
20
0.090
Why?
Outpatients
1
2016
440
0.090
Why?
Anti-Bacterial Agents
1
2023
1942
0.090
Why?
Anemia
1
2014
190
0.090
Why?
Hematologic Diseases
1
2012
66
0.090
Why?
Diagnosis, Computer-Assisted
1
2013
92
0.090
Why?
Lipids
1
2017
714
0.090
Why?
Decision Support Systems, Clinical
1
2016
279
0.090
Why?
Health Expenditures
1
2014
198
0.090
Why?
Cross-Sectional Studies
4
2024
5899
0.090
Why?
Drug Therapy, Combination
2
2009
1036
0.090
Why?
Hyperlipidemias
3
2017
120
0.080
Why?
Hospitalization
2
2018
2475
0.080
Why?
Evaluation Studies as Topic
1
2011
161
0.080
Why?
Chemical and Drug Induced Liver Injury
1
2012
138
0.080
Why?
Job Satisfaction
1
2013
236
0.080
Why?
Pregnancy
1
2024
7230
0.080
Why?
Venous Thromboembolism
1
2015
332
0.080
Why?
Diazepam
1
2010
32
0.080
Why?
Amiodarone
1
2010
31
0.080
Why?
Diabetes Mellitus, Type 2
2
2022
2623
0.080
Why?
Anti-Anxiety Agents
1
2010
46
0.080
Why?
Ipratropium
1
2009
4
0.080
Why?
Anticoagulants
1
2015
746
0.070
Why?
Case-Control Studies
3
2018
3647
0.070
Why?
Depression
2
2017
1575
0.070
Why?
Paroxetine
1
2009
8
0.070
Why?
Anti-Arrhythmia Agents
1
2010
144
0.070
Why?
Cytochrome P-450 CYP2D6
1
2009
33
0.070
Why?
Bupropion
1
2009
47
0.070
Why?
Mental Disorders
1
2018
1148
0.070
Why?
Heart Failure
1
2022
2329
0.070
Why?
Mibefradil
2
1998
9
0.070
Why?
Time Factors
4
2013
7109
0.070
Why?
Fluoxetine
1
2009
56
0.070
Why?
Kidney
1
2016
1498
0.070
Why?
Bronchodilator Agents
1
2009
186
0.070
Why?
Fees, Pharmaceutical
1
2008
8
0.070
Why?
Internet
1
2013
660
0.070
Why?
Telemedicine
1
2017
966
0.070
Why?
Prospective Studies
5
2015
8123
0.060
Why?
Blood Glucose
1
2017
2360
0.060
Why?
Surveys and Questionnaires
7
2018
6073
0.060
Why?
Sumatriptan
1
2006
6
0.060
Why?
Tryptamines
1
2006
5
0.060
Why?
Serotonin Receptor Agonists
1
2006
27
0.060
Why?
Financing, Personal
1
2005
26
0.060
Why?
Drugs, Generic
1
2005
28
0.060
Why?
Hypolipidemic Agents
2
2008
89
0.050
Why?
Dose-Response Relationship, Drug
1
2009
2022
0.050
Why?
Triazoles
1
2006
190
0.050
Why?
Incidence
1
2011
2936
0.050
Why?
Patients
1
2005
183
0.050
Why?
Anticholesteremic Agents
1
2005
156
0.050
Why?
Medical Records Systems, Computerized
2
2006
95
0.050
Why?
Age Factors
1
2011
3347
0.050
Why?
Proton Pump Inhibitors
1
2024
101
0.050
Why?
Mass Screening
1
2012
1307
0.050
Why?
Sex Factors
1
2009
2107
0.050
Why?
Medicaid
2
2017
477
0.050
Why?
Secondary Prevention
1
2024
248
0.050
Why?
Sodium Potassium Chloride Symporter Inhibitors
1
2022
17
0.050
Why?
Primary Prevention
1
2024
222
0.040
Why?
Pulmonary Disease, Chronic Obstructive
1
2009
928
0.040
Why?
Interviews as Topic
1
2026
930
0.040
Why?
Sodium
1
2022
196
0.040
Why?
Economics, Pharmaceutical
1
2000
10
0.040
Why?
Platelet Aggregation Inhibitors
1
2024
499
0.040
Why?
Treatment Outcome
3
2006
11821
0.040
Why?
Medication Systems, Hospital
1
1999
5
0.040
Why?
Federal Government
1
2018
23
0.030
Why?
Ambulatory Care Facilities
2
2017
269
0.030
Why?
Community Health Centers
1
2018
59
0.030
Why?
Veterans
2
2001
1650
0.030
Why?
Qualitative Research
1
2026
1734
0.030
Why?
Outpatient Clinics, Hospital
1
1998
80
0.030
Why?
Renal Insufficiency, Chronic
2
2014
640
0.030
Why?
Software
2
1999
676
0.030
Why?
Glucose
1
2022
1053
0.030
Why?
Vulnerable Populations
1
2018
178
0.030
Why?
Counseling
1
2000
406
0.030
Why?
Drug Dosage Calculations
1
2016
27
0.030
Why?
Contraindications
1
2016
88
0.030
Why?
Prescription Drug Misuse
1
2017
58
0.030
Why?
Health Status
1
2001
827
0.030
Why?
International Normalized Ratio
1
2015
55
0.030
Why?
Logistic Models
1
2000
2126
0.030
Why?
Epoetin Alfa
1
2014
9
0.030
Why?
Warfarin
1
2015
179
0.020
Why?
Longitudinal Studies
2
2014
3017
0.020
Why?
Publishing
1
2015
117
0.020
Why?
Erythropoietin
1
2014
100
0.020
Why?
Pain Management
1
2017
421
0.020
Why?
Clinical Trials as Topic
1
1998
1064
0.020
Why?
Cytochrome P-450 CYP3A Inhibitors
1
2012
18
0.020
Why?
Drug Overdose
1
2017
377
0.020
Why?
Acute Disease
1
2015
1038
0.020
Why?
Cytochrome P-450 CYP3A
1
2012
93
0.020
Why?
Chi-Square Distribution
1
2013
517
0.020
Why?
Specialization
1
2013
137
0.020
Why?
Insurance, Health, Reimbursement
1
2012
97
0.020
Why?
Recurrence
1
2015
1133
0.020
Why?
Education, Pharmacy
1
2013
125
0.020
Why?
Recombinant Proteins
1
2014
1361
0.020
Why?
Commission on Professional and Hospital Activities
1
2010
4
0.020
Why?
Thyrotropin
1
2010
120
0.020
Why?
Hemorrhage
1
2015
825
0.020
Why?
Alanine Transaminase
1
2010
151
0.020
Why?
Nebulizers and Vaporizers
1
2009
63
0.020
Why?
Data Interpretation, Statistical
2
2001
368
0.020
Why?
Spirometry
1
2009
234
0.020
Why?
Opioid-Related Disorders
1
2017
634
0.020
Why?
Models, Econometric
1
2008
35
0.020
Why?
Forced Expiratory Volume
1
2009
451
0.020
Why?
Comorbidity
1
2013
1665
0.020
Why?
Predictive Value of Tests
1
2013
2113
0.020
Why?
Drug Utilization
1
2008
171
0.020
Why?
Cardiology
1
2010
363
0.020
Why?
Electrocardiography
1
2010
667
0.020
Why?
Analgesics
1
2008
230
0.010
Why?
Prevalence
1
2012
2861
0.010
Why?
Prognosis
1
2013
4351
0.010
Why?
Pain
1
2008
790
0.010
Why?
Child, Preschool
1
2017
11913
0.010
Why?
Reproducibility of Results
2
1999
3416
0.010
Why?
Total Quality Management
1
2001
59
0.010
Why?
Health Status Indicators
1
2001
167
0.010
Why?
Quality-Adjusted Life Years
1
2000
122
0.010
Why?
Lipoproteins, LDL
1
2000
119
0.010
Why?
Treatment Refusal
1
2000
99
0.010
Why?
Diabetes Complications
1
2001
219
0.010
Why?
Multicenter Studies as Topic
1
2001
417
0.010
Why?
Linear Models
1
2001
857
0.010
Why?
Medical Records
1
1999
193
0.010
Why?
Health Services Research
1
2001
390
0.010
Why?
Quality Indicators, Health Care
1
2001
343
0.010
Why?
Attitude to Health
1
2001
421
0.010
Why?
Child
1
2017
22693
0.010
Why?
Patient Education as Topic
1
2000
770
0.010
Why?
Randomized Controlled Trials as Topic
1
2001
1763
0.010
Why?
Sensitivity and Specificity
1
1999
1998
0.010
Why?
Severity of Illness Index
1
1999
2921
0.010
Why?
Billups's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)